Literature DB >> 19056499

Multimodal imaging in mild cognitive impairment: Metabolism, morphometry and diffusion of the temporal-parietal memory network.

K B Walhovd1, A M Fjell, I Amlien, R Grambaite, V Stenset, A Bjørnerud, I Reinvang, L Gjerstad, T Cappelen, P Due-Tønnessen, T Fladby.   

Abstract

This study compared sensitivity of FDG-PET, MR morphometry, and diffusion tensor imaging (DTI) derived fractional anisotropy (FA) measures to diagnosis and memory function in mild cognitive impairment (MCI). Patients (n=44) and normal controls (NC, n=22) underwent FDG-PET and MRI scanning yielding measures of metabolism, morphometry and FA in nine temporal and parietal areas affected by Alzheimer's disease and involved in the episodic memory network. Patients also underwent memory testing (RAVLT). Logistic regression analysis yielded 100% diagnostic accuracy when all methods and ROIs were combined, but none of the variables then served as unique predictors. Within separate ROIs, diagnostic accuracy for the methods combined ranged from 65.6% (parahippocampal gyrus) to 73.4 (inferior parietal cortex). Morphometry predicted diagnostic group for most ROIs. PET and FA did not uniquely predict group, but a trend was seen for the precuneus metabolism. For the MCI group, stepwise regression analyses predicting memory scores were performed with the same methods and ROIs. Hippocampal volume and FA of the retrosplenial WM predicted learning, and hippocampal metabolism and parahippocampal cortical thickness predicted 5 minute recall. No variable predicted 30 minute recall independently of learning. In conclusion, higher diagnostic accuracy was achieved when multiple methods and ROIs were combined, but morphometry showed superior diagnostic sensitivity. Metabolism, morphometry and FA all uniquely explained memory performance, making a multi-modal approach superior. Memory variation in MCI is likely related to conversion risk, and the results indicate potential for improved predictive power by the use of multimodal imaging.

Entities:  

Mesh:

Year:  2008        PMID: 19056499     DOI: 10.1016/j.neuroimage.2008.10.053

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  35 in total

1.  Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Paul K Crane; Adam Carle; Laura E Gibbons; Philip Insel; R Scott Mackin; Alden Gross; Richard N Jones; Shubhabrata Mukherjee; S McKay Curtis; Danielle Harvey; Michael Weiner; Dan Mungas
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

2.  Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease.

Authors:  David S Karow; Linda K McEvoy; Christine Fennema-Notestine; Donald J Hagler; Robin G Jennings; James B Brewer; Carl K Hoh; Anders M Dale
Journal:  Radiology       Date:  2010-09       Impact factor: 11.105

3.  Decreased white matter integrity in neuropsychologically defined mild cognitive impairment is independent of cortical thinning.

Authors:  Nikki H Stricker; David H Salat; Jessica M Foley; Tyler A Zink; Ida L Kellison; Craig P McFarland; Laura J Grande; Regina E McGlinchey; William P Milberg; Elizabeth C Leritz
Journal:  J Int Neuropsychol Soc       Date:  2013-07-01       Impact factor: 2.892

4.  Disruption of limbic white matter pathways in mild cognitive impairment and Alzheimer's disease: a DTI/FDG-PET study.

Authors:  Andrea C Bozoki; Igor O Korolev; Nathan C Davis; Lori A Hoisington; Kevin L Berger
Journal:  Hum Brain Mapp       Date:  2011-06-14       Impact factor: 5.038

5.  Diffusion tensor imaging and cognitive function in older adults with no dementia.

Authors:  K Kantarci; M L Senjem; R Avula; B Zhang; A R Samikoglu; S D Weigand; S A Przybelski; H A Edmonson; P Vemuri; D S Knopman; B F Boeve; R J Ivnik; G E Smith; R C Petersen; C R Jack
Journal:  Neurology       Date:  2011-05-18       Impact factor: 9.910

6.  Glucose Dysregulation Interacts With APOE-∊4 to Potentiate Temporoparietal Cortical Thinning.

Authors:  Jessica M Foley; David H Salat; Nikki H Stricker; Regina E McGlinchey; William P Milberg; Laura J Grande; Elizabeth C Leritz
Journal:  Am J Alzheimers Dis Other Demen       Date:  2015-05-24       Impact factor: 2.035

7.  White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration.

Authors:  Kejal Kantarci; Christopher G Schwarz; Robert I Reid; Scott A Przybelski; Timothy G Lesnick; Samantha M Zuk; Matthew L Senjem; Jeffrey L Gunter; Val Lowe; Mary M Machulda; David S Knopman; Ronald C Petersen; Clifford R Jack
Journal:  JAMA Neurol       Date:  2014-12       Impact factor: 18.302

Review 8.  The role of diffusion tensor imaging in detecting microstructural changes in prodromal Alzheimer's disease.

Authors:  Bing Zhang; Yun Xu; Bin Zhu; Kejal Kantarci
Journal:  CNS Neurosci Ther       Date:  2013-12-12       Impact factor: 5.243

9.  Automated MRI measures predict progression to Alzheimer's disease.

Authors:  Rahul S Desikan; Howard J Cabral; Fabio Settecase; Christopher P Hess; William P Dillon; Christine M Glastonbury; Michael W Weiner; Nicholas J Schmansky; David H Salat; Bruce Fischl
Journal:  Neurobiol Aging       Date:  2010-06-08       Impact factor: 4.673

10.  Role of structural MRI in Alzheimer's disease.

Authors:  Prashanthi Vemuri; Clifford R Jack
Journal:  Alzheimers Res Ther       Date:  2010-08-31       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.